TherapeuticsMD Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.8%.

Top 25 shareholders own 31.76% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.3%	Rubric Capital Management LP	1,192,191	US$2.2m	0%	0.07%
4.04%	Clearline Capital LP	466,211	US$878.8k	2.38%	0.1%
3.49%	Tejara Capital Limited., Asset Management Arm	401,937	US$757.7k	8.75%	0.29%
3.36%	The Vanguard Group, Inc.	387,582	US$730.6k	0.61%	no data
2.36%	ADAR1 Capital Management, LLC	272,160	US$513.0k	0%	0.21%
1.18%	BlackRock, Inc.	136,263	US$256.9k	-0.18%	no data
1.14%	Morgan Stanley, Investment Banking and Brokerage Investments	131,767	US$248.4k	-1.03%	no data
1.05%	Hugh O’Dowd	121,666	US$229.3k	0%	no data
0.74%	Geode Capital Management, LLC	84,788	US$159.8k	0%	no data
0.56%	Brian Bernick	64,966	US$122.5k	0%	no data
0.54%	Marlan Walker	62,565	US$117.9k	439%	no data
0.54%	Michael Donegan	61,853	US$116.6k	0%	no data
0.41%	Cooper Collins	46,722	US$88.1k	0%	no data
0.36%	Bridgeway Capital Management, LLC	42,000	US$79.2k	0%	no data
0.26%	State Street Global Advisors, Inc.	30,100	US$56.7k	-0.09%	no data
0.25%	GAMCO Investors, Inc.	29,000	US$54.7k	-6.45%	no data
0.23%	Mark Glickman	27,060	US$51.0k	0%	no data
0.19%	Columbia Management Investment Advisers, LLC	22,479	US$42.4k	-0.08%	no data
0.18%	Thomas Thompson	20,287	US$38.2k	0%	no data
0.14%	Northern Trust Global Investments	16,491	US$31.1k	0%	no data
0.12%	J. Goldman & Co., L.P.	13,562	US$25.6k	0%	no data
0.088%	Dimensional Fund Advisors LP	10,154	US$19.1k	0%	no data
0.072%	FMR LLC	8,289	US$15.6k	0%	no data
0.061%	Charles Schwab Investment Management, Inc.	7,060	US$13.3k	0%	no data
0.051%	Paul Bisaro	5,922	US$11.2k	0%	no data